We are live on ! Find out more
MRNA icon

Moderna

962 hedge funds and large institutions have $30.2B invested in Moderna in 2023 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 308 increasing their positions, 380 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.48% more ownership

Funds ownership: 64.65% → 65.13% (+0.48%)

10% less call options, than puts

Call options by funds: $1.32B | Put options by funds: $1.46B

5% less funds holding

Funds holding: 1,015 → 962 (-53)

14% less capital inflows, than outflows

Capital inflows: $1.44B | Capital outflows: $1.67B

17% less funds holding in top 10

Funds holding in top 10: 18 → 15 (-3)

19% less repeat investments, than reductions

Existing positions increased: 308 | Existing positions reduced: 380

47% less first-time investments, than exits

New positions opened: 66 | Existing positions closed: 124

Holders
962
Holders Change
-53
Holders Change %
-5.22%
% of All Funds
15.06%
Holding in Top 10
15
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-16.67%
% of All Funds
0.23%
New
66
Increased
308
Reduced
380
Closed
124
Calls
$1.32​B
Puts
$1.46​B
Net Calls
-⁠$141​M
Net Calls Change
-⁠$519​M

MRNA Hedge Fund Activity: Q2 2023 in Review

962 of the 6,386 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q2 2023, worth a combined $30.2B — down 21% from $38.4B a quarter earlier.

Sellers outnumbered buyers: 124 funds closed out of MRNA and 66 opened new positions — a net loss of 58 holders — while 380 trimmed existing stakes and 308 added.

The largest buyer was Morgan Stanley, adding an estimated $116M. The largest seller was BlackRock, cutting an estimated $124M.

  • 962 institutional investors held Moderna (MRNA) as of Q2 2023, down from 1,015 in Q1 2023.
  • Funds reported $30.2B of Moderna stock for Q2 2023, down 21% quarter-over-quarter.
  • 66 funds opened new Moderna positions in Q2 2023 and 124 closed out, a net change of -58 holders.
  • The largest Moderna buyer in Q2 2023 was Morgan Stanley, an estimated $116M added.
  • The largest Moderna seller in Q2 2023 was BlackRock, an estimated $124M sold.

Based on aggregated 13F filings for Q2 2023.